Tempo Therapeutics, Inc.

New Filing

CIK: 0001813688·Biotechnology·DELAWARE·Filed: Jun 2, 2020

Total Offering

$3,898,500

Amount Sold

$3,844,046

Investors

39

First Sale

May 21, 2020

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Westbrook Weaver	Related Person
Donald Griffin	Related Person
Steven Richieri	Related Person
Richard Hancock	Related Person
Dino Di Carlo	Related Person

Company

Tempo Therapeutics, Inc.

3030 BUNKER HILL STREET

SAN DIEGO, CA, 92109

(251) 654-4070

SEC Filing

0001813688-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.